Can Diamox (acetazolamide) cause metabolic acidosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Acetazolamide (Diamox) and Metabolic Acidosis

Yes, Diamox (acetazolamide) does cause metabolic acidosis as a direct pharmacological effect of its mechanism of action as a carbonic anhydrase inhibitor.

Mechanism of Acetazolamide-Induced Acidosis

  • Acetazolamide inhibits carbonic anhydrase, which produces a metabolic acidosis by increasing bicarbonate excretion in the kidneys 1
  • This metabolic acidosis is non-anion gap in nature and is a direct pharmacological effect, not an adverse reaction 2
  • The inhibition of carbonic anhydrase V in mitochondria can impair the tricarboxylic acid cycle, potentially worsening acidosis by affecting pyruvate carboxylase function 3

Severity and Prevalence

  • In a study of elderly patients receiving acetazolamide for glaucoma, 37% developed moderate metabolic acidosis (pH 7.20-7.29) and 3.7% developed severe acidosis (pH <7.20) 4
  • The acidosis can range from mild and transient to severe and clinically significant 5
  • Metabolic acidosis is common enough that it's mentioned in the FDA drug label as an expected pharmacological effect 2

Risk Factors for Severe Acidosis

  • Patients with renal impairment are at higher risk for developing significant acidosis 2, 6
  • Concomitant use with high-dose aspirin significantly increases the risk of severe metabolic acidosis 2, 6
  • Patients with chronic obstructive pulmonary disease (COPD) or other respiratory conditions are at increased risk due to impaired respiratory compensation 5
  • Elderly patients appear to be more susceptible to clinically significant acidosis 4
  • Patients who have undergone nephrectomy or have other forms of reduced renal function are at higher risk 5

Monitoring and Management

  • The FDA recommends periodic monitoring of serum electrolytes for patients on acetazolamide therapy 2
  • The acidotic state can usually be corrected by the administration of bicarbonate if clinically necessary 2
  • In severe cases, discontinuation of acetazolamide may be required 6
  • Blood pH levels and serum electrolytes (particularly potassium) should be monitored in patients at risk 2

Clinical Applications and Considerations

  • In some clinical contexts, the acidosis induced by acetazolamide is actually therapeutically beneficial, such as in the treatment of acute mountain sickness where it helps offset respiratory alkalosis 7
  • For management of edema in nephrotic syndrome, acetazolamide may be used as part of combination diuretic therapy, but with awareness of its effect on acid-base balance 1
  • Acetazolamide has no role in the routine management of obstructive sleep apnea due to limited efficacy and poor tolerability, with metabolic acidosis being one of the limiting factors 1

Special Precautions

  • Acetazolamide should be avoided in patients with severely impaired renal function or those undergoing dialysis 6
  • It should be used with caution in patients with pulmonary obstruction or emphysema where alveolar ventilation may be impaired, as it may precipitate or aggravate acidosis 2
  • Patients receiving concomitant high-dose aspirin and acetazolamide require close monitoring due to reports of severe acidosis, anorexia, tachypnea, lethargy, and even death 2, 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Pathogenic mechanism, prophylaxis, and therapy of symptomatic acidosis induced by acetazolamide.

Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 2002

Research

Metabolic acidosis induced by acetazolamide.

Journal of the American Optometric Association, 1991

Research

Mechanisms of action of acetazolamide in the prophylaxis and treatment of acute mountain sickness.

Journal of applied physiology (Bethesda, Md. : 1985), 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.